Terumo Corp 4543
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- JPY 2,574.50
- Day Range
- JPY 2,513.00–2,565.00
- 52-Week Range
- JPY 1,856.00–3,014.50
- Bid/Ask
- JPY 2,538.00 / JPY 2,545.00
- Market Cap
- JPY 3.77 Tril
- Volume/Avg
- 4.0 Mil / 4.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- 16.87
- Price/Sales
- 4.33
- Dividend Yield (Trailing)
- 0.85%
- Dividend Yield (Forward)
- 0.85%
- Total Yield
- 1.38%
Company Profile
Terumo Corp manufactures and sells medical products and equipment. The firm has three main businesses: blood management, cardiac and vascular, and general hospital. The cardiac and vascular business generates the largest proportion of revenue and sells cardiac and endovascular interventional therapies, cardiovascular surgical systems, neurovascular products, and vascular graft products. The general hospital business includes diabetes management, consumer healthcare, drug and device technologies, and general hospital products. The blood management business sells blood component, therapeutic apheresis, and cellular technologies. Terumo generates the majority of its revenue in Asia, with Japan contributing the largest proportion of Asian revenue.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Large Growth
- Total Number of Employees
- 30,207
- Website
- https://www.terumo.com
Comparables
Valuation
|
Metric
|
4543
|
NVRO
|
NUVA
|
|---|---|---|---|
Price/Earnings (Normalized) | 16.87 | — | 19.87 |
Price/Book Value | 3.15 | 1.53 | 2.34 |
Price/Sales | 4.33 | 1.04 | 1.79 |
Price/Cash Flow | 23.23 | — | 11.86 |
Price/Earnings
4543
NVRO
NUVA
Financial Strength
|
Metric
|
4543
|
NVRO
|
NUVA
|
|---|---|---|---|
Quick Ratio | 1.03 | 4.82 | 0.60 |
Current Ratio | 1.90 | 6.37 | 1.25 |
Interest Coverage | 45.59 | −12.98 | 2.90 |
Quick Ratio
4543
NVRO
NUVA
Profitability
|
Metric
|
4543
|
NVRO
|
NUVA
|
|---|---|---|---|
Return on Assets (Normalized) | 6.04% | −5.64% | 4.87% |
Return on Equity (Normalized) | 8.50% | −11.08% | 12.28% |
Return on Invested Capital (Normalized) | 7.08% | −7.81% | 6.21% |
Return on Assets
4543
NVRO
NUVA
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Zwjqjswk | Dhpc | $132.1 Bil | |
BDX
| Becton Dickinson & Co | Sdxzygfc | Vcjyjc | $67.4 Bil | |
ALC
| Alcon Inc | Kcnyjrww | Bphsh | $39.1 Bil | |
CLPBY
| Coloplast A/S ADR | Jfgdkblzpw | Svvt | $28.8 Bil | |
WST
| West Pharmaceutical Services Inc | Fbtlmpknf | Fvgw | $27.6 Bil | |
RMD
| ResMed Inc | Nfwvxfjvk | Tndmnwd | $26.1 Bil | |
BAX
| Baxter International Inc | Nhjldlhkb | Bfrzry | $20.2 Bil | |
COO
| The Cooper Companies Inc | Bnpwgjjy | Fydbbg | $18.0 Bil | |
HOLX
| Hologic Inc | Qmqgmqj | Xpqxnw | $17.6 Bil | |
TFX
| Teleflex Inc | Sytz | Vrbk | $9.8 Bil |